Coatue Discloses 9.9% Stake in Hinge Health (HNGE) — 2.96M Shares
Coatue and affiliated entities report a significant passive stake in Hinge Health's Class A stock.
Rhea-AI Filing Summary
Coatue and affiliated entities report a significant passive stake in Hinge Health's Class A stock. The filing discloses aggregate beneficial ownership of 2,960,200 shares by Coatue Management and Philippe Laffont, equal to 9.9% of the Class A shares. Two affiliated vehicles are separately disclosed: Coatue Growth Fund IV LP holds 2,401,696 shares (8.1%) and Coatue US 70 LLC holds 2,300,512 shares (7.9%). The reported shares include those directly held and those issuable upon conversion of Class B common stock, and all reported holdings are shown as shared voting and dispositive power with no sole voting or sole dispositive power.
Positive
- Material stake disclosed: Coatue-related reporting persons hold 2,960,200 Class A shares representing 9.9% of the class.
- Transparency on composition: Filing specifies that reported shares include those issuable upon conversion of Class B common stock.
Negative
- No sole voting or dispositive power: All reported shares are shown with shared voting and shared dispositive power, indicating no unilateral control by a single reporting person.
Insights
Coatue's near-10% stake is material and could influence market perception but does not imply sole control.
The Schedule 13G shows Coatue-related entities and Philippe Laffont beneficially own 2.96 million Class A shares (9.9%). For investors, a sub-10% passive disclosure signals meaningful economic exposure without an expressed intent to exert control. The filing clarifies that ownership includes shares issuable upon conversion of Class B stock, which can affect dilution and voting calculations. Shared voting and dispositive power indicates coordination among affiliates rather than unilateral control, so corporate governance outcomes remain subject to broader shareholder composition.
Material ownership is disclosed but absence of sole voting power limits immediate governance impact.
The report documents shared voting and dispositive authority over the disclosed shares and explicitly shows zero sole voting or dispositive power across reporting persons. That structure suggests Coatue acts in concert across advisory clients and funds. While a nearly 10% economic stake is noteworthy, the lack of sole voting control means any board or strategic influence would likely require cooperation with other shareholders or formal engagement declared in future filings.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Hinge Health (HNGE) does Coatue report?
Which Coatue entities are named in the Schedule 13G for Hinge Health (HNGE)?
AI-generated analysis. How Rhea-AI works. Not financial advice.